https://braintumorinvestmentfund.org/news/alpheus-medical-closes-16m-in-series-a-financing-for-novel-glioma-brain-cancer-treatment/ 2022-07-21T21:10:21+00:00 https://braintumorinvestmentfund.org/news/delmar-pharmaceuticals-receives-500000-loan-from-the-national-brain-tumor-society-and-national-foundation-for-cancer-research-to-support-val-083s-participation-in-a-pivotal-study-for-glioblastoma/ 2022-07-21T21:12:16+00:00 https://braintumorinvestmentfund.org/news/fda-grants-alpheus-medical-orphan-drug-and-fast-track-designations-for-novel-sonodynamic-therapy-for-brain-cancer/ 2022-07-21T21:18:22+00:00 https://braintumorinvestmentfund.org/news/accelerating-glioblastoma-therapeutics-via-venture-philanthropy/ 2022-07-21T21:19:17+00:00 https://braintumorinvestmentfund.org/news/science-publication-first-to-describe-modifi-bios-novel-approach-to-fight-cancer-cells-with-dna-modification/ 2022-08-01T18:24:22+00:00 https://braintumorinvestmentfund.org/news/brain-tumor-investment-fund-names-managing-director/ 2023-05-18T22:44:18+00:00 https://braintumorinvestmentfund.org/news/kiyatec-announces-investment-from-leading-brain-cancer-venture-philanthropy-funds/ 2023-05-18T22:48:40+00:00 https://braintumorinvestmentfund.org/news/cordance-medical-and-exact-therapeutics-announce-strategic-partnership-to-revolutionize-drug-delivery-to-the-brain/ 2023-09-07T17:47:38+00:00 https://braintumorinvestmentfund.org/news/mimivax-announces-new-investments-to-support-clinical-development-of-survaxm-in-glioblastoma/ 2024-01-09T17:23:11+00:00 https://braintumorinvestmentfund.org/news/enclear-therapies-inc-secures-additional-funding-to-advance-neuro-oncology-innovations/ 2024-09-04T13:21:01+00:00 https://braintumorinvestmentfund.org/news/btif-portfolio-company-kiyatec-announces-publication-of-groundbreaking-study-on-3d-predict-glioma-in-high-grade-glioma-hgg-patients/ 2024-10-23T12:40:13+00:00 https://braintumorinvestmentfund.org/news/modifi-biosciences-acquired-by-merck/ 2024-10-23T12:50:00+00:00 https://braintumorinvestmentfund.org/news/alpheus-medical-announces-positive-phase-1-2-trial-results-for-the-treatment-of-recurrent-high-grade-gliomas/ 2024-11-26T17:56:43+00:00 https://braintumorinvestmentfund.org/news/trogenix-unveils-revolutionary-platform-to-transform-cancer-treatment-through-precision-viral-immunotherapy/ 2024-11-26T17:57:20+00:00 https://braintumorinvestmentfund.org/news/cordance-medical-and-exact-therapeutics-announce-early-encouraging-data-in-brain-cancer-mice-model/ 2025-01-30T14:53:02+00:00 https://braintumorinvestmentfund.org/news/mimivax-announces-positive-interim-analysis-in-ongoing-survaxm-clinical-trial/ 2025-02-13T14:31:30+00:00 https://braintumorinvestmentfund.org/news/alpheus-medical-publishes-early-clinical-results-of-sonodynamic-therapy-for-the-treatment-of-newly-diagnosed-glioblastomas/ 2025-02-26T20:53:32+00:00 https://braintumorinvestmentfund.org/news/alpheus-medical-raises-52m-in-series-b-round-to-advance-groundbreaking-glioblastoma-therapy/ 2025-05-15T15:16:07+00:00 https://braintumorinvestmentfund.org/news/diakonos-oncology-closes-20-million-financing-to-accelerate-phase-2-glioblastoma-clinical-development-program-and-expand-use-of-innovative-dendritic-cell-platform-for-studies-in-other-indications/ 2025-10-06T15:56:58+00:00 https://braintumorinvestmentfund.org/news/trogenix-announces-95-million-series-a-financing-to-drive-clinical-development-of-potentially-curative-therapies-for-aggressive-cancers/ 2025-10-06T15:58:31+00:00 https://braintumorinvestmentfund.org/news/cordance-medical-announces-an-oversubscribed-8m-seed-financing-to-advance-focused-ultrasound-platform-for-brain-disease-treatment/ 2025-11-24T21:11:32+00:00 https://braintumorinvestmentfund.org/news/forbes-clinical-trial-for-brain-cancer-treatment-has-promising-results/ 2026-04-02T21:03:27+00:00 https://braintumorinvestmentfund.org/news/trogenix-publishes-glioblastoma-gene-therapy-research-in-nature/ 2026-04-13T18:52:36+00:00 https://braintumorinvestmentfund.org/news/alpheus-medical-initiates-phase-2b-trial-of-investigational-therapy-for-newly-diagnosed-glioblastoma/ 2026-04-14T19:52:24+00:00 https://braintumorinvestmentfund.org/news/fox-26-houston-diakonoss-experimental-immunotherapy-for-glioblastoma-shows-promising-survival-gains-in-early-trials/ 2026-04-16T18:58:09+00:00